Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiation Therapy With and Without Rituximab for Patients With Stage I II Follicular Lymphoma Grade I/II
NCT01473628Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- May 2013
- Primary completion
- May 2027
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in follicular lymphoma (FL), sponsored by University of Texas MD Anderson Cancer Center. Started May 2013; status: active, not recruiting.
02
Drugs
rituximab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01473628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01473628.